Nedergaard; Maiken

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nedergaard; Maiken.The latest application filed is for "glymphatic delivery by manipulating plasma osmolarity".

Company Profile

1.7.15

Nedergaard; Maiken - Rochester NY
NEDERGAARD; Maiken - Webster NY
Nedergaard; Maiken - South Salem NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Glymphatic Delivery By Manipulating Plasma Osmolarity App 20220280423 - Nedergaard; Maiken ; et al.	2022-09-08
Glymphatic Delivery By Manipulating Plasma Osmolarity App 20220031867 - Nedergaard; Maiken ; et al.	2022-02-03
Methods Of Treating Neuropsychiatric Disorders App 20200197445 - GOLDMAN; Steven A. ; et al.	2020-06-25
Methods for evaluating brain-wide paravascular pathway for waste clearance function and methods for treating neurodegenerative disorders based thereon Grant 9,901,650 - Nedergaard , et al. February 27, 2	2018-02-27
Method of treating and preventing brain impairment using Na.sup.+-K.sup.+-2Cl-cotransporter isoform 1 inhibitors Grant 9,616,075 - Nedergaard , et al. April 11, 2	2017-04-11
Methods For Evaluating Brain-wide Paravascular Pathway For Waste Clearance Function And Methods For Treating Neurodegenerative Disorders Based Thereon App 20160000945 - Nedergaard; Maiken ; et al.	2016-01-07
METHOD OF TREATING AND PREVENTING BRAIN IMPAIRMENT USING Na+-K+-2Cl- COTRANSPORTER ISOFORM 1 INHIBITORS App 20150202215 - Nedergaard; Maiken ; et al.	2015-07-23
Enhancing The Therapeutic Effect Of Acupuncture With Adenosine App 20130005676 - Nedergaard; Maiken	2013-01-03
Purine receptor inhibition as a therapeutic strategy in spinal cord and brain Grant 7,923,448 - Nedergaard , et al. April 12, 2	2011-04-12
Adenosine And Its Mimetics. Modulators, Transport Inhibitors, And Receptor Agonists As A Therapeutic Tool To Replace Or Improve The Efficacy Of Deep Brain Stimulation App 20100284984 - Nedergaard; Maiken	2010-11-11
Purines are self-renewal signals for neural stem cells, and purine receptor antagonists promote neuronal and glial differentiation therefrom Grant 7,829,332 - Goldman , et al. November 9, 2	2010-11-09
Treatment And Prevention Of Epilepsy App 20100029613 - Nedergaard; Maiken ; et al.	2010-02-04
Treatment of glial tumors with glutamate antagonists Grant 7,250,394 - Nedergaard July 31, 2	2007-07-31
Treatment Of Glial Tumors With Glutamate Antagonists App 20070135413 - Nedergaard; Maiken	2007-06-14
Purines are self-renewal signals for neural stem cells, and purine receptor antagonists promote neuronal and glial differentiation therefrom App 20050181503 - Goldman, Steven A. ; et al.	2005-08-18
Purine receptor inhibition as a therapeutic strategy in spinal cord and brain App 20050164975 - Nedergaard, Maiken ; et al.	2005-07-28
Discovery, localization, harvest, and propagation of an FGF2 and BDNF-responsive population of neural and neuronal progenitor cells in the adult human forebrain App 20050112109 - Goldman, Steven A. ; et al.	2005-05-26
Discovery, localization, harvest, and propagation of an FGF2 and BDNF-responsive population of neural and neuronal progenitor cells in the adult human forebrain Grant 6,812,027 - Goldman , et al. November 2, 2	2004-11-02
Discovery, Localization, Harvest, And Propagation Of An Fgf2 And Bdnf-responsive Population Of Neural And Neuronal Progenitor Cells In The Adult Human Forebrain App 20030049234 - GOLDMAN, STEVEN A. ; et al.	2003-03-13
Treatment of glial tumors with glutamate antagonists App 20030050224 - Nedergaard, Maiken	2003-03-13

Company Registrations

NCAGE Code	48T92	NEDERGAARD MAIKEN
CAGE Code	48T92	NEDERGAARD, MAIKEN

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.